Certainty in the Critical Moments: A New Standard for Sepsis Management
Navigate the complexities of sepsis with diagnostic tools engineered for unparalleled consistency, providing the critical data you need when every minute counts.
The Race Against Time: The Clinical Challenge of Sepsis
Sepsis, a life-threatening organ dysfunction from a dysregulated host response to infection, demands immediate and precise intervention. With high mortality rates and diagnostically ambiguous early-stage symptoms, rapid and reliable biomarker data is essential for timely treatment and adherence to critical care protocols like the Surviving Sepsis Campaign bundles.
Optimizing the Sepsis Care Pathway
Our solution integrates seamlessly into the critical sepsis workflow, providing key data points that support rapid triage, accurate diagnosis, and ongoing patient monitoring.
1. ED Triage & Suspicion
Rapidly assess patients presenting with signs of infection to identify those at high risk for sepsis.
RECOMMENDED TEST:
reOpenTest CRP Rapid Test2. Diagnosis & Risk Stratification
Differentiate bacterial from viral infections and stratify patient risk using quantitative biomarker measurements.
RECOMMENDED TEST:
reOpenTest PCT Quantitative Assay3. ICU & Therapeutic Monitoring
Monitor patient response to antibiotic therapy with serial PCT measurements to help guide treatment duration.
RECOMMENDED TEST:
reOpenTest PCT Quantitative AssayThe Foundation of Clinical Confidence
Why Our Biomarker Assays Are More Reliable
In sepsis management, consistency is not a luxury—it's a clinical necessity. The NomoFlow™ platform is the core reason for our tests' exceptionally low batch-to-batch variation (CV < 3%). This manufacturing precision ensures that a change in patient PCT levels is confidently attributed to their clinical condition, not test variability. We eliminate the 'black box risk' from the diagnostic process, providing a verifiable foundation for critical decisions.
Performance You Can Depend On
Our sepsis biomarker assays are designed to meet the demanding accuracy requirements of critical care settings.
reOpenTest PCT Quantitative Assay Performance
| Metric | Value |
|---|---|
| Sensitivity | 98.5% |
| Specificity | 99.2% |
| Limit of Detection | 0.05 ng/mL |
Evidence-Based Practice
The clinical utility of Procalcitonin and C-Reactive Protein in sepsis management is well-documented. Explore the research that underpins our solutions.
Our Sepsis Management Toolkit
reOpenTest PCT Quantitative Assay Kit
For the rapid, quantitative measurement of Procalcitonin, a key biomarker for bacterial sepsis.
View Product DetailsreOpenTest CRP Rapid Test Kit
A rapid, semi-quantitative test for C-Reactive Protein to aid in the assessment of infection and inflammation.
View Product DetailsFIA-1000 Immunoassay Analyzer
The compact, reliable analyzer that powers our quantitative assays at the point of care.
View Product DetailsEnhance Your Sepsis Protocol with Verifiable Reliability
Our team of clinical application specialists is ready to help you integrate our NomoFlow™-powered diagnostic solutions into your existing sepsis protocols to improve efficiency and patient outcomes. Contact us to schedule a consultation.
Speak with a Workflow Specialist